Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 46

1.

Deconvoluting MLL1-dependent pathways in hematopoiesis and leukemogenesis.

Mishra BP, Ernst P.

Leuk Suppl. 2014 Dec;3(Suppl 1):S9-S10. doi: 10.1038/leusup.2014.5. Epub 2014 Dec 17. No abstract available.

2.

New Abelson interactor-1 (Abi-1)-driven mechanism of acquired drug resistance.

Chorzalska A, Dubielecka PM.

Leuk Suppl. 2014 Dec;3(Suppl 1):S7-8. doi: 10.1038/leusup.2014.4. Epub 2014 Dec 17. No abstract available.

3.

STAT3 as a mediator of BCR-ABL1-independent resistance in chronic myeloid leukemia.

Eiring AM, Kraft IL, Page BD, O'Hare T, Gunning PT, Deininger MW.

Leuk Suppl. 2014 Dec;3(Suppl 1):S5-6. doi: 10.1038/leusup.2014.3. Epub 2014 Dec 17. No abstract available.

4.

Dissecting reprogramming, differentiation and conversion with network biology.

Daley GQ.

Leuk Suppl. 2014 Dec;3(Suppl 1):S3-4. doi: 10.1038/leusup.2014.2. Epub 2014 Dec 17. No abstract available.

5.

Insights into the pathophysiology and therapy of myeloproliferative neoplasms from mouse models.

Van Etten RA.

Leuk Suppl. 2014 Dec;3(Suppl 1):S27-8. doi: 10.1038/leusup.2014.15. Epub 2014 Dec 17. No abstract available.

6.

Myeloid differentiation and the leukemia-initiating cell.

Tenen DG.

Leuk Suppl. 2014 Dec;3(Suppl 1):S25-6. doi: 10.1038/leusup.2014.14. Epub 2014 Dec 17. No abstract available.

7.

The polycythemia vera stem cell.

Spivak JL.

Leuk Suppl. 2014 Dec;3(Suppl 1):S23-4. doi: 10.1038/leusup.2014.13. Epub 2014 Dec 17. No abstract available.

8.

Adoptive immunotherapy for myeloid malignancies.

Reagan JL.

Leuk Suppl. 2014 Dec;3(Suppl 1):S21-2. doi: 10.1038/leusup.2014.12. Epub 2014 Dec 17. No abstract available.

9.

Novel view on hematopoietic stem cell mobilization and homing.

Ratajczak MZ.

Leuk Suppl. 2014 Dec;3(Suppl 1):S19-20. doi: 10.1038/leusup.2014.11. Epub 2014 Dec 17. No abstract available.

10.

Adult marrow hematopoiesis: a continuum of change.

Quesenberry PJ, Goldberg L, Dooner M, Pereira M, Aliotta J.

Leuk Suppl. 2014 Dec;3(Suppl 1):S18. doi: 10.1038/leusup.2014.10. Epub 2014 Dec 17. No abstract available.

11.

Mechanisms of graft-versus-leukemia effects after allogeneic stem cell transplantation: effects on the leukemia stem cell?

Kolb HJ, Schmetzer H, Schmid C, Bigalke I, Buhmann R, Moosmann A, Falk C, Reuther S, Schuster F, Borkhardt A.

Leuk Suppl. 2014 Dec;3(Suppl 1):S16-7. doi: 10.1038/leusup.2014.9. Epub 2014 Dec 17. No abstract available.

12.

Targeting leukemia stem cells with HDAC inhibitors and modulators of the DNA damage response.

Grant S.

Leuk Suppl. 2014 Dec;3(Suppl 1):S14-5. doi: 10.1038/leusup.2014.8. Epub 2014 Dec 17. No abstract available.

13.

Reconsidering marrow stem cell cycle status: insights into an actively cycling hematopoietic stem cell population.

Goldberg LR.

Leuk Suppl. 2014 Dec;3(Suppl 1):S12-3. doi: 10.1038/leusup.2014.7. Epub 2014 Dec 17. No abstract available.

14.

Harnessing alloreactivity to achieve anti-leukemic responses.

Fast LD.

Leuk Suppl. 2014 Dec;3(Suppl 1):S11. doi: 10.1038/leusup.2014.6. Epub 2014 Dec 17. No abstract available.

15.

Altered microenvironmental regulation of CML stem cells.

Bhatia R.

Leuk Suppl. 2014 Dec;3(Suppl 1):S1-2. doi: 10.1038/leusup.2014.1. Epub 2014 Dec 17. No abstract available.

16.

Challenges in multiple myeloma diagnosis and treatment.

Girnius S, Munshi NC.

Leuk Suppl. 2013 May;2(Suppl 1):S3-9. doi: 10.1038/leusup.2013.2. Epub 2013 May 8. Review.

17.

Conclusion: advances in current treatment for patients with newly diagnosed multiple myeloma.

Lonial S.

Leuk Suppl. 2013 May;2(Suppl 1):S28-9. doi: 10.1038/leusup.2013.6. Epub 2013 May 8. Review. No abstract available.

18.

Advances in treatment for newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplantation.

San Miguel JF, Mateos MV.

Leuk Suppl. 2013 May;2(Suppl 1):S21-7. doi: 10.1038/leusup.2013.5. Epub 2013 May 8. Review.

19.

Optimizing outcomes for patients with newly diagnosed multiple myeloma eligible for transplantation.

Moreau P, Touzeau C.

Leuk Suppl. 2013 May;2(Suppl 1):S15-20. doi: 10.1038/leusup.2013.4. Epub 2013 May 8. Review.

20.

Stem cell transplantation for multiple myeloma: current and future status.

Giralt S, Bensinger W.

Leuk Suppl. 2013 May;2(Suppl 1):S10-4. doi: 10.1038/leusup.2013.3. Epub 2013 May 8. Review.

Supplemental Content

Loading ...
Support Center